Clinical Trial: An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07863167) titled 'An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.' on Sept. 30.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR-A2009 combined with other anti-tumor therapies for perioperative treatment of resectable non-small cell lung cancer in adults.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Non-small Cell Lung Cancer

Intervention: DRUG: adebrelimab + SHR-A2009

adebrelimab + SHR-A2009

DRUG: paclitaxel or pemetrexed combined with carboplatin +adebrelimab

pacli...